Exploration and correlation analysis of changes in Krebs von den Lungen-6 levels in COVID-19 patients with different types in China
Mingshan Xue(First Affiliated Hospital of Guangzhou Medical University), Nanshan Zhong(First Affiliated Hospital of Guangzhou Medical University), Baoqing Sun(First Affiliated Hospital of Guangzhou Medical University), Zhifeng Huang(Central South University), Jian‐Lin Wu(Macau University of Science and Technology), Xiqing Bian(Macau University of Science and Technology), Xiaoqing Liu(Jiangsu Province Hospital), Yifeng Zeng(First Affiliated Hospital of Guangzhou Medical University), Huimin Huang(Wuhan University), Haisheng Hu(First Affiliated Hospital of Guangzhou Medical University), Luqian Zhou(First Affiliated Hospital of Guangzhou Medical University), Peiyan Zheng(First Affiliated Hospital of Guangzhou Medical University)
Cited by 36
Related Papers
Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2016|2.1k
Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
|New England Journal of Medicine|2013|654
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients
|Emerging Microbes & Infections|2020|535
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
|Nature Communications|2020|247
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
|The Lancet Respiratory Medicine|2021|183